Zymewire

SEPTEMBER 15, 2023

The bill also enables Medicare to negotiate prescription drug prices and extends the Affordable Care Act through 2025. Signed into law in August 2022, the Inflation Reduction Act (IRA) was designed to fight inflation, invest in domestic (US) energy production & manufacturing, and reduce carbon emissions.

Biopharma 52

Biopharma Prescription Manufacturing 52

MedCity News

JULY 30, 2023

The FDA approved RiVive, an over-the-counter version of naloxone nasal spray from Harm Reduction Therapeutics. It’s the second such approval from the FDA this year, following an affirmative decision in March for OTC Narcan.

FDA 98

FDA Prescription Pharma Biopharma 98

MedCity News

JULY 21, 2023

What we need to overcome adherence challenges is a digitally enabled marketplace of options that can be personalized to the patient and the context of their specific condition, pharmacy preference and ability to pay.

Prescription 98

Prescription Patients Biopharma Medical 98

MedCity News

JANUARY 23, 2023

As pharma becomes part of the value-based revolution, there are several lessons that can be learned from the ongoing development of value-based care.

Prescription 98

Prescription Pharma Biopharma 98

MedCity News

MARCH 13, 2023

Price transparency has come a long way over the past couple of years, with insurance companies and hospitals now required to publicly disclose their prices. The more pressing issue is that there is no mechanism in place to make this information easily digestible, personalized to each patient, and placed in context with competitors’ prices.

Doctors 96

Doctors Prescription Insurance Patients 96

MedCity News

DECEMBER 8, 2023

Prescriptions for GLP-1s are soaring, but fewer than a third of people prescribed the costly drugs will continue taking them one year later without personalized support.

Prescription 117

Prescription Biopharma 117

MedCity News

OCTOBER 17, 2022

President Biden continues to center his pre-midterm speeches around the issue of prescription drug costs, […].

Prescription 136

Prescription Biopharma 136

MedCity News

FEBRUARY 4, 2024

In 2023, prescription drug costs rose by 8.4%, a 31% increase from the prior year. By enforcing transparency, PBMs would need to release detailed information on prescription drug spending. 2024 stands at a critical juncture in the battle against soaring pharmacy costs. Transparency and reporting requirements.

Prescription 119

Prescription Networking Management Pharmaceutical 119

World of DTC Marketing

MARCH 16, 2022

Besides the increased costs of prescription drugs above inflation levels, drug companies are playing a shell game with the opioid settlements. Analysts expect that “big biopharma” companies will collectively have more than $500 billion in cash to deploy by 2022.

Pharma 183

Pharma Government Biopharma Prescription 183

MedCity News

APRIL 2, 2023

Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech.

FDA 122

FDA Prescription Biopharma Pharma 122

pharmaphorum

JULY 18, 2022

The separation leaves GSK as a biopharma and vaccines pure-play that chief executive Emma Walmsley has said will deliver £33 billion in annual revenues by 20231, up from £24.5 Last year, GSK rejected a $68 billion bid from Unilever for the consumer health operations, saying the offer “fundamentally undervalued” the business.

Biopharma 101

Biopharma Sales Prescription Pharma 101

MedCity News

JULY 13, 2023

FDA approval of Opill makes it the first oral contraceptive that may be used without a prescription. Clinicians say over-the-counter availability will lower barriers to access to a key component of reproductive healthcare.

FDA 98

FDA Prescription Healthcare Healthcare 98

MedCity News

APRIL 10, 2023

Pear Therapeutics’ Chapter 11 bankruptcy filing follows three corporate restructurings and the inability to secure additional financing to support commercialization of its FDA-cleared prescription digital therapeutics. An auction of Pear’s assets is expected to happen in early May.

Prescription 113

Prescription FDA Biopharma 113

MedCity News

AUGUST 27, 2023

doctor visits, prescription pickups) and enriching our insights with the micro-moments surrounding these obvious events. The Walt Disney Company excels in designing exceptional service because they are hyper-focused on listening, tracking, designing, and measuring the experiences of guests visiting their properties.

Healthcare 96

Healthcare Healthcare Prescription Doctors 96

MedCity News

MARCH 19, 2023

Pear Therapeutics isn’t meeting the commercialization goals for its prescription digital therapeutics, so it’s now seeking strategic alternatives for the business. Prospective buyers can pick up Pear’s FDA-cleared products for substance use disorder, opioid use disorder, and insomnia.

Prescription 98

Prescription Prospecting FDA Biopharma 98

MedCity News

OCTOBER 24, 2022

Specialty carve outs that move specialty drugs away from traditional prescription drug management to a pharmacy benefit administrator (PBA) or specialty administrator will continue and likely to provide cost savings.

Prescription 109

Prescription Pharmaceutical Patients Management 109

MedCity News

DECEMBER 27, 2022

Earlier this year, CMS implemented a new Level II Healthcare Common Procedure Coding System (HCPCS) code for “prescription digital behavioral therapy,” which makes it easier for commercial and Medicaid plans to cover these therapies. Additionally.

Healthcare 97

Healthcare Healthcare Prescription Biopharma 97

MedCity News

JULY 28, 2022

Prescription digital therapeutics can and should be considered as part of type 2 diabetes therapies. While pharmaceuticals are a critical piece of the treatment landscape for type 2 diabetes, they have been the exclusive and de-facto first-line treatment for too long.

Pharmaceutical 120

Pharmaceutical Prescription Biopharma 120

MedCity News

JULY 11, 2023

Better Therapeutics prescription digital therapeutic, AspyreRx, received De Novo FDA authorization for type 2 diabetes. The mobile app digitizes and personalizes cognitive behavioral therapy.

FDA 75

FDA Prescription Biopharma Medical 75

Clarivate

OCTOBER 25, 2023

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. In both cases, a shift in formulary placement could lower prescription volumes and reduce member utilization. With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

pharmaphorum

OCTOBER 24, 2022

Sumitomo and its subsidiary Sumitovant Biopharma initially offered $22.75 At the time, Myovant said Myfembree was the market leader in the oral GnRH category with a 51% share in new prescriptions for uterine fibroids that was keeping it ahead of main rival AbbVie/Neurocrine Biosciences’ Orilissa/Oriahnn (elagolix).

Biopharma 63

Biopharma Pharma Prescription Marketing 63

pharmaphorum

JUNE 12, 2017

Market access is influencing drug development and commercial launch strategy more than ever before, with 85% of prescription drugs in the United States reimbursed through managed care plans.

Marketing 52

Marketing Engineering Biopharma Prescription 52

Pharmaceutical Technology

NOVEMBER 4, 2022

For example, digital twins of pharmaceutical supply chains can predict bottlenecks and give suggestions for how to respond using prescriptive AI. The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

pharmaphorum

JULY 27, 2022

Demerging Haleon has allowed GSK to focus on higher-margin prescription medicines and vaccines, as well as provide cash for investment in its biopharma pipeline. Total revenues came in at £6.9 billion ($8.3 GSK has already made moves in this direction this year with deals to buy cancer specialist Sierra Oncology for $1.9 billion.

Sales 52

Sales Biopharma Prescription Medicine 52

pharmaphorum

SEPTEMBER 26, 2022

Mackay has been CFO at the UK big pharma since the beginning of 2019, and is departing the company shortly after the spin-out of consumer health business Haleon in order to focus on prescription drugs and vaccines. billion and $1.9 billion, respectively.

Management 52

Management Pharma Biopharma Prescription 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

The speciality drug channel participants, including speciality pharmacies, biopharma companies, and distributors, are transforming their operations with automated and secure data systems and next-generation analytics, which will improve data collection, partner performance and strategy effectiveness. . Prescription refill and renewal.

Specialization 45

Specialization Leads Pharma Side effects 45

pharmaphorum

DECEMBER 23, 2022

With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance. Food and Drug Administration’s Office of Prescription Drug Promotion ( OPDP ).”.

Marketing 93

Marketing Sales Medical Patients 93

pharmaphorum

JUNE 24, 2022

Digital health company Happify has signed a partnership with another biopharma company, joining forces with Biogen on a toolkit to help people with multiple sclerosis manage their illness. ” The post Biogen and Happify partner on digital support for MS patients appeared first on.

Patients 40

Patients Prescription Biopharma Insurance 40

Pharmaceutical Technology

JANUARY 31, 2023

Inflation Reduction Act Speaking during the keynote panel “FDA & ARPA-H: Life Sciences, Biopharma & Medtech Priorities in a New Year”, Califf discussed the Inflation Reduction Act of August 2022, which aims to lower prescription drug prices.

FDA 52

FDA Prescription Medicine Biopharma 52

The Marketing Advantage

SEPTEMBER 11, 2023

prescription, new prescriber, etc.) Request a free consultation with us today to get started on designing the best commission-based sales compensation plan for your biopharma product! that the sales representative achieves. The commission is most often either a set amount for each unit (i.e., $200

Sales 52

Sales Consulting Biopharma Prescription 52

Clarivate

DECEMBER 14, 2021

Patients are most active searching for online health information when preparing for a doctor visit, when 19% do so; after a doctor’s appointment (20%); and after receiving a prescription but before getting it filled (19%).More 2021 study had researched prescription drug topics online in the past year.

Pharma 52

Pharma Healthcare Healthcare Physicians 52

PM360

JULY 21, 2022

The medication referenced in this case study is a prescription medication used, along with diet and exercise, to lower blood sugar in adults with type 2 diabetes. Veradigm provides biopharma marketers an opportunity to deliver awareness messages directly to the HCPs of interest, during their point of care workflow.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

Veeva

AUGUST 15, 2021

Quickly confirm specialty data, prescriptive authority, and sample eligibility to ensure compliance with regulations and privacy laws. Some of the largest pharmaceutical companies in the world, as well as emerging biopharma, use Veeva OpenData to increase field force effectiveness, boost productivity and enhance customer engagement.

Sales 52

Sales Healthcare Healthcare Healthcare Provider 52

Clarivate

APRIL 18, 2024

RxPass offers more than 50 select prescriptions at no additional cost for $5 per month. In classic Amazon style, its pharmacy offers two-day shipping on prescriptions by mail, with same-day delivery available in seven markets, with plans to add a dozen more cities by year end.

Retail 52

Retail Healthcare Healthcare Physicians 52

Clarivate

JULY 5, 2023

biologics market and reduce prescription drug costs. By end of year, as many as ten adalimumab biosimilars could be on the U.S. The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. In 2022, it made its manufacturer, AbbVie, $21.2bn.

Marketing 97

Marketing Physicians Manufacturing Competition 97

Clarivate

OCTOBER 30, 2022

One exception is Pear Therapeutics, which has not only secured FDA clearance but also required a prescription for its reSET-O and Somryst apps. If Congress passes the Access to Prescription Digital Therapeutics Act, the market would be reinvigorated with the establishment of a payment methodology for Medicare reimbursement.

Insurance 52

Insurance FDA Prescription Marketing 52

MedCity News

JUNE 16, 2023

The earliest higher-profile digital therapeutic leaders focused on mental and behavioral health with some earning Food and Drug Administration approval for managing conditions such as attention-deficit and hyperactivity disorder, substance-use disorder, and insomnia using a prescription-level app alone or in conjunction with pharmacologic therapy.

Pharma 122

Pharma Food and Drug Administration Recruitment Pharmacology 122